Genomic & Biopharma News

With pricing outcry raging, U.S. drug spending grew less than 1% last year: CMS
Congress and the Trump administration are riled up about drug prices and promising to drive them down. But a new government report shows that U.S. spending on retail pharmaceuticals grew less than half of 1% last year—far less than the rate in recent years.
Fierce Pharma, 2018-12-07 14:13:41

DiaMedica pulls off IPO to fund midphase stroke trial
DiaMedica Therapeutics has wrapped up its IPO. The offering gives DiaMedica the cash to take its lead candidate through phase 2 trials in acute ischemic stroke and chronic kidney disease.
Fierce Biotech, 2018-12-07 13:43:56

Surgical choices may have long-term impact on quality of life for breast cancer patients
Even as more young women with breast cancer opt to have mastectomies, many experience a persistent decline in their sexual and psychosocial well-being following the procedure, as detailed in new research by Dana-Farber/Brigham and Women's Cancer Center.
News Medical Life Sciences, 2018-12-07 13:32:20

With Tesaro off the block, will Clovis be the next PARP maker to get swallowed up?
Clovis, which markets PARP inhibitor Rubraca for ovarian cancer, has struggled to keep up with rivals like Tesaro's Zejula and AstraZeneca and Merck’s Lynparza. That's one of several challenges that have some biopharma experts speculating Clovis will be snapped up by an asset-hungry Big Pharma player.
Fierce Pharma, 2018-12-07 13:27:57

FiercePharmaAsia—Takeda-Shire finish line; Sun’s crisis; J&J-Legend CAR-T
The Takeda-Shire megamerger won go-aheads from shareholders; Sun Pharma plummets on reports of a potential government probe and governance issues; J&J and Legend update results from an early-stage myeloma trial testing their much-hyped CAR-T therapy; and more.
Fierce Pharma, 2018-12-07 13:21:56

BioLineRx‘s Immunotherapy AGI-134 Receives FDA’s Biological Product Designation

Immuno-Oncology News, 2018-12-07 13:00:46

Many people at risk of heart disease and stroke have excess abdominal fat
Nearly two-thirds of people who are at high risk of cardiovascular disease and stroke have excess fat around the middle of the body (central obesity), according to findings from the European Society of Cardiology (ESC) EUROASPIRE V survey.
News Medical Life Sciences, 2018-12-07 12:37:16

Electronic Sun Sentinel: Gene analysis lab moves to Deerfield Beach

ORB Company News, 2016-12-02 21:24:27

Rat Study Points to Role of Uterus in Memory
When researchers removed the reproductive organ, female rats had more difficulty solving a water maze.
The Scientist, 2018-12-07 12:12:09

Electronic Sun Sentinel: Gene analysis lab moves to Deerfield Beach

ORB Company News, 2016-12-02 21:24:27

Roche’s Tecentriq wins key lung cancer approval. Its prize? A showdown with formidable Merck
Merck’s Keytruda finally has some immuno-oncology competition in first-line, non-small cell lung cancer, courtesy of Roche. But even with an FDA approval in the bag, the real test for Roche might still be to come.
Fierce Pharma, 2018-12-07 12:03:28